Black Diamond Therapeutics, Inc. - Common Stock (BDTX)

Historical Holders from Q1 2020 to Q3 2025

Type / Class
Equity / Common Stock
Symbol
BDTX on Nasdaq
Shares outstanding
56,078,244
Price per share
$3.98
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
38,780,810
Total reported value
$146,973,938
% of total 13F portfolios
0%
Share change
+164,912
Value change
+$5,639,486
Number of holders
89
Price from insider filings
$3.98
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Black Diamond Therapeutics, Inc. - Common Stock (BDTX) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BB BIOTECH AG 4.8% -69% $3,881,637 -$8,213,695 2,733,547 -68% BB Biotech AG 19 Mar 2025
BlackRock, Inc. 4.5% $3,583,400 2,523,521 BlackRock, Inc. 31 Mar 2025
As of 30 Sep 2025, Black Diamond Therapeutics, Inc. - Common Stock (BDTX) has 89 institutional shareholders filing 13F forms. They hold 38,780,810 shares. of 56,078,244 outstanding shares (69%) .

Top 25 institutional shareholders own 65% of the company.

Filer Ownership Nb Shares Share Change % Portfolio % Holdings Value
T. Rowe Price Investment Management, Inc. 19% 10,744,107 +2.2% 0.02% $40,721,000
Vestal Point Capital, LP 9.9% 5,550,000 -0.89% 0.95% $21,034,500
NEA Management Company, LLC 7.9% 4,448,757 0% 0.93% $16,860,789
VANGUARD GROUP INC 3.9% 2,188,857 +4.1% 0% $8,295,768
TANG CAPITAL MANAGEMENT LLC 3.7% 2,070,209 0% 0.3% $7,846,092
MARSHALL WACE, LLP 2.3% 1,299,208 +76% 0.01% $4,923,996
Siren, L.L.C. 1.9% 1,046,517 0% 0.16% $3,966,299
BlackRock, Inc. 1.8% 1,028,092 -5.8% 0% $3,896,470
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP 1.6% 896,853 +549% 0% $3,399,073
MILLENNIUM MANAGEMENT LLC 1.5% 850,331 -10% 0% $3,222,754
UBS Group AG 1.1% 628,416 +100% 0% $2,381,696
AWM Investment Company, Inc. 1.1% 600,000 +20% 0.21% $2,274,000
RENAISSANCE TECHNOLOGIES LLC 1.1% 599,400 +259% 0% $2,271,726
GEODE CAPITAL MANAGEMENT, LLC 0.89% 500,523 +1% 0% $1,897,600
NORTHERN TRUST CORP 0.87% 488,064 +222% 0% $1,849,763
ACADIAN ASSET MANAGEMENT LLC 0.86% 481,123 0% $1,820,000
DIMENSIONAL FUND ADVISORS LP 0.81% 455,870 0% 0% $1,727,463
FMR LLC 0.81% 453,558 +9.6% 0% $1,718,985
GOLDMAN SACHS GROUP INC 0.8% 449,018 +28% 0% $1,701,779
DAFNA Capital Management LLC 0.55% 307,070 -35% 0.29% $1,163,795
GLOBEFLEX CAPITAL L P 0.54% 305,276 0.18% $1,156,996
JANE STREET GROUP, LLC 0.42% 237,273 +14% 0% $899,265
STIFEL FINANCIAL CORP 0.4% 222,245 +1% 0% $842,310
XTX Topco Ltd 0.39% 216,195 +21% 0.04% $819,379
STATE STREET CORP 0.38% 213,513 0% 0% $809,214

Institutional Holders of Black Diamond Therapeutics, Inc. - Common Stock (BDTX) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 38,780,810 $146,973,938 +$5,639,486 $3.79 89
2025 Q2 38,616,493 $95,766,554 -$4,378,950 $2.48 92
2025 Q1 40,656,241 $63,018,032 -$11,756,465 $1.55 83
2024 Q4 47,903,841 $102,515,530 -$13,782,463 $2.14 84
2024 Q3 48,717,118 $211,892,116 +$1,571,338 $4.35 101
2024 Q2 46,507,345 $216,732,253 +$31,760,223 $4.66 87
2024 Q1 39,430,152 $199,909,697 +$10,432,400 $5.07 85
2023 Q4 38,888 $109,275 +$77,601 $2.81 1
2023 Q3 37,179,830 $106,707,397 -$21,938,151 $2.87 69
2023 Q2 41,419,893 $209,166,921 +$105,446,084 $5.05 69
2023 Q1 21,491,692 $40,616,899 +$846,737 $1.89 46
2022 Q4 21,052,863 $37,893,729 -$751,714 $1.80 54
2022 Q3 21,451,239 $36,251,000 -$315,195 $1.69 54
2022 Q2 20,962,480 $51,577,000 -$3,653,802 $2.46 54
2022 Q1 20,059,301 $55,595,531 -$1,845,680 $2.77 63
2021 Q4 20,172,596 $107,500,132 -$13,365,863 $5.33 77
2021 Q3 23,610,319 $199,838,028 -$12,530,903 $8.46 86
2021 Q2 24,796,493 $302,261,425 -$88,608,277 $12.19 96
2021 Q1 29,083,808 $705,518,054 -$7,562,837 $24.26 109
2020 Q4 26,925,965 $863,001,806 +$135,299,760 $32.05 107
2020 Q3 23,764,080 $718,480,421 +$754,061 $30.23 87
2020 Q2 22,751,913 $955,924,654 +$40,650,763 $42.16 77
2020 Q1 22,284,581 $555,208,061 +$555,208,043 $24.95 64